15
Participants
Start Date
June 6, 2016
Primary Completion Date
January 10, 2017
Study Completion Date
January 10, 2017
Liothyronine sodium
Subjects will be divided into 4 groups of progressively escalating doses. Each group will have 6 subjects 4 will receive the active treatment and 2 will receive the placebo. The first group will receive 25 mcg twice daily for one week. The second group will receive 37.5 mcg twice daily for one week. The third group will receive 50 mcg twice daily for one week. The forth group will receive 75 mcg twice daily for one week.
Placebo
Patient will receive a matching placebo to take twice daily for one week.
Oregon Health and Science University, Portland
Oregon Health and Science University
OTHER